Some ruthenium (II) polypyridyl complexes with a bis-chalconc (obtained by the condensation of 3-mcthylthiophcnc-2-carboxaldchydc and 4-acctyl pyridinc) have bccn synthesized and characterized spectroscopically (IR, NMR., UV/Vis), conductimetric, elemental analysis and FAB mass data. Their luminescent, redox and LV binding properties have been studied The anti-HIV and antiturnour activities have also bccn reported..
Introduction
Studies of ruthenium (II) polypyridyl complexes have been interesting owing to their unique photophysical and redox characteristics [1] . In fact, these properties have led to the development of new ruthenium polypyridyl systems either by incorporating the desired groups within the bipyridine moiety itself or by using other type of donor sites along with the [Ru(bpy/phen)2] core to form mixed ligand tris-chelates modulating the photo-redox activities of this class of complexes.
Furthermore, it has been reported that Ru(II) complexes bind DNA and a correlation between their binding affinity and activities have already been established [2, 3] . Recently a detailed accounts of such properties of ruthenium complexes have been reviewed by Clarke et a/. [4] . Based on antiviral [5] , antifungal [6] , antibacterial [7] and antitumour [8] activities of chalcones very recently, several Ru(II) complexes bearing bis-chalcones synthesized by us [9] have been evaluated for their antitumour and anti-HIV activities [10] and some of them have shown quite interesting properties. It was therelbre considered worthwhile to explore some new Ru(II) complexes bearing chalcones for the evaluation of their antitumour and anti-HIV properties.
The Li / binding properties of newly synthesized complexes containing 14-membered ring are also studied.
Materials and Methods
All the solvents purchased from Merck were distilled using standard procedures prior to use. 3-Methylthiophene-2-carboxaldehye, 4-aeetyl pyridine, 2,2'-bipyridine and 1,10-phenanthroline purchased from Sigma-Aldrich were used as supplied whereas the cis-[Ru(bpy)2Cl2] and cis-pRu(phen)2C12] were prepared by a reported [11] procedure. Tetra-n-butylammonium bromide supplied by Merck was converted into pure tetrabutyl ammonium perchlorate (TBAP) by an available procedure [12] . Table I .
Results and Discussion
The synthesis of ligand has been considered in view of Michael addition [14] (Scheme-I). Figure 1 Room temperature emission spectra Emission properties of the complexes have been studied in acetonitrile solution (10 6 M) at room temperature (excitation at 450 nm). Complexes did not luminesce most likely due to the efficient migration of the electron/energy [16] [17] [18] from the triplet excited state of Ru" to the ligand, as probability of non-radiative emission was discarded since complex (2) During the reduction of the free ligand two peaks were observed at -0.85 and -1.2 V. However, four reduction peaks were observed at -0.8,-1.1, -1.35 and-1.55 V in the cyclic voltammogram of complex (1). The reduction peaks at -0.8 and -1.1 V were assigned to arise from ligand reduction whereas the peaks at -1.35 and -1.55 V could " considered to arise from bipyridine reduction in view of earlier report [19] . Similarly four reduction peaks at -0.45, -1.2, -1.35 and -1.8 V also arise upon reduction of the complex (2) which were in consistence with the earlier report [20] . (Table III) . Characterization 
Antitumour and anti-HIV activities
The antitumour and anti-HIV activities were evaluated using standard procedure [22, 23] . The cytotoxicity data of free ligand alongwith their ruthenium complexes are shown in Table IV . The free ligand showed potential activity against IA9 and A549 which could be considered [24] in view of the significant bioactivities shown by an earlier ligand system bearing similar functional (-N-C-O) group. However, the complexes showed a better activity as compared to the free ligand against almost all tumour cells. This inhibitory behaviour of the complexes may be considered in view of their interaction with DNA as reported [25, 26] [27] . Complex (2) bearing a bulkier group (1,10-phenanthroline) did not show activities (NA inhibition < or 5% at 20 g/mL). The activity of these compounds has been compared with the standard AZT (azidothymidine) treated as control under the similar experimental conditions. 
